|Guidelines for the use and interpretation of assays for monitoring autophagy|
DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ...
Autophagy 12 (1), 1-222, 2016
|Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH|
S Bekri, P Gual, R Anty, N Luciani, M Dahman, B Ramesh, A Iannelli, ...
Gastroenterology 131 (3), 788-796, 2006
|Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation|
S Bekri, G Kispal, H Lange, E Fitzsimons, J Tolmie, R Lill, DF Bishop
Blood, The Journal of the American Society of Hematology 96 (9), 3256-3264, 2000
|Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation|
C Brasse–Lagnel, Z Karim, P Letteron, S Bekri, A Bado, C Beaumont
Gastroenterology 140 (4), 1261-1271. e1, 2011
|The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, Type 2 diabetes, and NASH|
R Anty, S Bekri, N Luciani, MC Saint-Paul, M Dahman, A Iannelli, IB Amor, ...
American Journal of Gastroenterology 101 (8), 1824-1833, 2006
|Detailed map of a region commonly amplified at 11q13→ q14 in human breast carcinoma|
S Bekri, J Adelaide, S Merscher, J Grosgeorge, F Caroli-Bosc, ...
Cytogenetic and Genome Research 79 (1-2), 125-131, 1997
|Disruption of autophagy at the maturation step by the carcinogen Lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal–regulated kinase …|
E Corcelle, M Nebout, S Bekri, N Gauthier, P Hofman, P Poujeol, ...
Cancer research 66 (13), 6861-6870, 2006
|Porphyria cutanea tarda and antibodies to hepatitis C virus|
JP Lacour, I Bodokh, J Castanet, S Bekri, JP Ortonne
British Journal of Dermatology 128 (2), 121-123, 1993
|Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B‐cell malignancies|
SD Raynaud, S Bekri, D Leroux, J Grosgeorge, B Klein, C Bastard, ...
Genes, Chromosomes and Cancer 8 (2), 80-87, 1993
|Omics-based strategies in precision medicine: toward a paradigm shift in inborn errors of metabolism investigations|
A Tebani, C Afonso, S Marret, S Bekri
International journal of molecular sciences 17 (9), 1555, 2016
|Autophagosome maturation is impaired in Fabry disease|
M Chévrier, N Brakch, L Céline, D Genty, Y Ramdani, S Moll, ...
Autophagy 6 (5), 589-599, 2010
|Evidence for a role of sphingosine-1 phosphate in cardiovascular remodelling in Fabry disease|
N Brakch, O Dormond, S Bekri, D Golshayan, M Correvon, L Mazzolai, ...
European heart journal 31 (1), 67-76, 2010
|Clinical results of enzyme replacement therapy in Fabry disease: a comprehensive review of literature|
O Lidove, D Joly, F Barbey, S Bekri, JF Alexandra, V Peigne, R Jaussaud, ...
International journal of clinical practice 61 (2), 293-302, 2007
|Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia|
C Michot, L Hubert, NB Romero, A Gouda, A Mamoune, S Mathew, E Kirk, ...
Journal of inherited metabolic disease 35 (6), 1119-1128, 2012
|Clinical metabolomics: the new metabolic window for inborn errors of metabolism investigations in the post-genomic era|
A Tebani, L Abily-Donval, C Afonso, S Marret, S Bekri
International journal of molecular sciences 17 (7), 1167, 2016
|Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation|
R Anty, M Dahman, A Iannelli, P Gual, A Staccini-Myx, IB Amor, N Luciani, ...
Obesity surgery 18 (6), 709-714, 2008
|The role of ceramide trihexoside (globotriaosylceramide) in the diagnosis and follow-up of the efficacy of treatment of Fabry disease: a review of the literature|
S Bekri, O Lidove, R Jaussaud, B Knebelmann, F Barbey
Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly …, 2006
|Fabry disease in patients with end-stage renal failure: the potential benefits of screening|
S Bekri, A Enica, T Ghafari, G Plaza, I Champenois, G Choukroun, ...
Nephron Clinical Practice 101 (1), c33-c38, 2005
|Hemojuvelin: a new link between obesity and iron homeostasis|
N Luciani, C Brasse‐Lagnel, M Poli, R Anty, C Lesueur, M Cormont, ...
Obesity 19 (8), 1545-1551, 2011
|A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia|
S Bekri, A May, PD Cotter, AI Al-Sabah, X Guo, GS Masters, DF Bishop
Blood 102 (2), 698-704, 2003